SCHEDULE 13G Filed 2026-09-08 Event — SEC 0001274173-26-000222 →

Janus Henderson Group Ltd. → EYEPOINT, INC. EYPT

Stake: — Shares: — Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-08-31

DTC 1.72

18,110,761 shares short · -1.7% vs prior

Other 13D/G Filings on EYEPOINT, INC.

Filed	Form	Filer	Stake	Shares
2026-06-03	SCHEDULE 13G	Commodore Capital LP	—	—	view →
2019-02-13	SC	EW Healthcare Partners, L.P.	—	—	view →
2018-07-05	SC	EW Healthcare Partners, L.P.	—	—	view →

Other Filings by Janus Henderson Group Ltd.

Filed	Form	Issuer	Stake	Shares
2026-09-08	SCHEDULE 13G	VOGENX, INC.	—	—	view →
2026-08-13	SCHEDULE 13G	ACHIEVE LIFE SCIENCES, INC.	—	—	view →
2026-07-08	SCHEDULE 13G	PRIVACORE VPC ASSET BACKED CREDIT FUND	—	—	view →
2026-07-08	SCHEDULE 13G	PRIVACORE PCAAM ALTERNATIVE INCOME FUND	—	—	view →
2026-07-08	SCHEDULE 13G	PRIVACORE PCAAM ALTERNATIVE GROWTH FUND	—	—	view →
2026-06-05	SCHEDULE 13G	CELLECTAR BIOSCIENCES, INC. CLRB	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →